Arhaus (NASDAQ:ARHS) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.12 by 133.33 percent.
VistaGen Shares Plunge Amid Uncertainty Around Its Anxiety Trial
After the markets closed on Tuesday, VistaGen Therapeutics Inc (NASDAQ:VTGN) reported a Q3 FY23 net loss of $(9.8) million or $(0.05) per…